Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure
Abstract Inflammatory cardiomyopathy diagnosed by endomyocardial biopsy (EMB) is common in non-ischemic heart failure (HF) and might be associated with adverse outcome. We aimed to identify markers predicting myocardial inflammation in HF. We screened 517 patients with symptomatic non-ischemic HF wh...
Guardado en:
Autores principales: | S. Schwuchow-Thonke, S. Göbel, T. Emrich, V. H. Schmitt, F. Fueting, C. Klank, F. Escher, H. P. Schultheiss, T. Münzel, K. Keller, P. Wenzel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97bd0631699f446bb0e09d710f876b91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers of acute myocardial infarction in the elderly: troponin and beyond
por: Rains MG, et al.
Publicado: (2014) -
The prognostic role of high-sensitivity cardiac troponin T over time in ischemic and non-ischemic heart failure
por: Siyuan Li, et al.
Publicado: (2021) -
Prognostic value of GLS for early prediction of chemotherapy induced cardiotoxicity
por: Sumit Vipin Kumar, et al.
Publicado: (2021) -
Total numbers and in-hospital mortality of patients with myocardial infarction in Germany during the FIFA soccer world cup 2014
por: Karsten Keller, et al.
Publicado: (2021) -
Troponin and anti-troponin autoantibody levels in patients with ventricular noncompaction.
por: Hatice Betül Erer, et al.
Publicado: (2013)